Effect of Recombinant FVIII in Healthy Male Subjects Treated With TB-402
Clinical trial NCT00612417 · COMPLETED
Trial details
- NCT number
- NCT00612417
- Sponsor
- ThromboGenics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.